Modern Synthesis raises $5.5m to expand biomaterials platform

Modern Synthesis has secured $5.5 million in a Seed 2 funding round led by Extantia Capital, with participation from Artesian and Collaborative Fund. This financing will enable the London-based startup to enhance production capabilities and meet demand from fashion brands on its waitlist.

Original excerpt: Modern Synthesis—a London-based startup developing biomaterials for high-end fashion brands—has closed a $5.5 million round led by Extantia Capital…

Source: AgFunderNews